Hematopathology Consultation Services
With over 11 board-certified hematopathologists, the Department of Laboratory Medicine at the University of California, San Francisco offers second opinion and expert consultation services for adult and pediatric patients with benign and malignant hematologic disorders. Specimens that may be submitted for evaluation include peripheral blood, bone marrow, lymph nodes, spleen and other tissue. In addition to morphologic evaluation, we offer comprehensive ancillary testing as required.
When submitting material for evaluation, please:
- Include completed Hemepath-Consult requisition form.
- Specify if you would like a specific hematopathologist to review your case, otherwise the case will be assigned to the pathologist on the consultation service.
- Include a cover letter with patient's name, age, gender, brief clinical history, specimen type and your case number.
- Provide a copy of the patient's preliminary or final pathology report.
- Include all stained slides, including immunostains, and a representative formalin-fixed paraffin block or 15 unstained slides, along with a copy of all pathology reports and other pertinent reports (flow cytometry, cytogenetics, etc.)
- Send all material to:
UCSF Laboratory Medicine - Hematopathology
Attn: Iryna Yarova
University of California, San Francisco
505 Parnassus Ave., L554
San Francisco, CA 94143-0451
Phone: (415) 353-1672
Fax: (415) 353-1106
Core Faculty for Consultative Services:
Karthik Ganapathi, MD, PhD
Chief of Hematopathology
Dr. Ganapathi is a clinical assistant professor of Pathology in the Department of Laboratory Medicine at UCSF. He is board -certified in hematopathology, anatomic pathology and clinical pathology.
Dr. Ganapathi earned his medical degree at Kilpauk Medical College, Chennai, India and his doctorate from Boston University School of Medicine. He then completed his residency in anatomic and clinical pathology from the University of Buffalo followed by a hematopathology fellowship at the National Institutes of Health/National Cancer Institute, under the supervision of Elaine Jaffe, MD.
Before joining UCSF, Dr. Ganapathi was a hematopathologist at Columbia University Medical Center, New York. Dr. Ganapathi specializes in the diagnosis of lymphoid and myeloid neoplasms and his clinical and research interests include morphologic and immunophenotypic characterization of myeloid neoplasms, lymphoproliferative disorders and pediatric hematopathology.
Sonam Prakash, MD
Dr. Prakash is a clinical professor of Pathology in the Department of Laboratory Medicine at UCSF. She is board certified in hematopathology, anatomic pathology and clinical pathology.
Dr. Prakash completed medical school at Lady Hardinge Medical College, New Delhi, India and residency in anatomic and clinical pathology at Temple University Hospital, Philadelphia and Cedars-Sinai Medical Center, Los Angeles. She then completed a fellowship in oncologic pathology at Memorial Sloan Kettering Cancer Center, New York, followed by a hematopathology fellowship at the National Institutes of Health/National Cancer Institute, under the supervision of Elaine Jaffe, MD.
Before joining UCSF, Dr. Prakash was a hematopathologist at University of Pittsburgh Medical Center with Steven Swerdlow, MD, furthering her expertise in lymph node pathology. She then worked at Weill Cornell Medical Center, New York with Attilio Oraziz, MD, an expert in myeloproliferative neoplasms, and myelodysplastic syndromes/myeloproliferative neoplasms. Dr. Prakash specializes in the diagnosis of myeloid and lymphoid neoplasms. Her research interests include myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms. In addition to her clinical and research interests, Dr. Prakash is the director of the UCSF Hematopathology Fellowship program.
Yi Xie, MD, PhD
Dr. Xie is a clinical assistant professor of Pathology in the Department of Laboratory Medicine at UCSF. She is board certified in hematopathology, anatomic pathology and clinical pathology.
Dr. Xie received her medical degree from Peking University Health Science Center in Beijing, China, and her doctorate from the University of Alabama at Birmingham. She completed her residency in anatomic and clinical pathology at the University of Souther California followed by a hematopathology fellowship at the National Institutes of Health/National Cancer Institute, under the supervision of Elaine Jaffe, MD.
Before joining UCSF, Dr. Xie was a hematopathologist at Duke University Medical Center, Durham, NC. Yi specializes in the diagnosis of hematologic neoplasms including leukemias, lymphomas, myelomas, myelodysplastic syndroms and myeloproliferative neoplasms. Her research interests include immunophenotypic and molecular characterization of myeloid and lymphoid neoplasms, as well as their reactive mimics.
Parul Bhargava, MD
Dr. Bhargava is a professor in the Department of Laboratory Medicine at UCSF and the Director for the UCSF Clinical Laboratories. She is board certified in hematopathology, anatomic pathology and clinical pathology.
Dr. Bhargava graduated from Lady Hardinge Medical College, University of Delhi, New Delhi, India in 1994, completed residency in anatomic and clinical pathology at Georgetown University Medical Center, Washington DC in 2001 and fellowship in hematopathology at Beth Israel Deaconess Medical Center in 2002.
Before joining UCSF, Dr. Bhargava was an assistant professor of pathology at Harvard Medical School. She was a staff hematopathologist, associate program director for the hematopathology fellowship training program and directed the Clinical Hematology, Coagulation and Flow Cytometry Laboratories at Beth Israel Deaconess Medical Center, Boston MA for 15 years. Dr. Bhargava has authored numerous peer-review publications, practice guidelines and textbooks and has been an active educator on the national level, lecturing on numerous topics in hematopathology. In addition, she has served on national and international committees for several organizations, including the College of American Pathologists, the Society of Hematopathologists, the International Society of Laboratory Hematology and the American Society of Hematology. Dr. Bhargava's research interests are in studying bioldogical markers in hematopoietic malignancies as well as in laboratory evaluation of coagulation disorders.
Linlin Wang, MD, PhD
Dr. Wang is a clinical assistant professor of Pathology in the Department of Laboratory Medicine at UCSF and the Medical Director for the Hematology Laboratory at Mission Bay. She is board certified in hematopathology, anatomic pathology and clinical pathology.
Dr. Wang completed medical school and her doctorate at Tongji Medical College, Wuhan, China and residency in anatomic and clinical pathology at University of Texas Southwestern Medical Center, Dallas, Texas. She then completed a fellowship in hematopathology at UCSF, followed by a surgical pathology/GI & liver pathology clinical instructorship at UCSF.
Before starting her residency, Dr. Wang studied the detection of minimal residual disease by flow cytometry with Dr. Mike Loken at Hematologics/Fred Hutchinson Cancer Research Center, Seattle. Dr. Wang specializes in pediatric hematology and the diagnosis of benign and malignant hematolymphoid disorders. Her research interests include molecular and immunophenotypic features of myeloid and lymphoid neoplasms.
Joseph Rohr, MD, PhD
Dr. Rohr is an assistant professor in the Department of Laboratory Medicine at UCSF. He is board certified in hematopathology, and anatomic and clinical pathology.
Dr. Rohr earned his MD and PhD, and completed his residency in anatomic and clinical pathology, at the University of Nebraska Medical Center, Omaha, NE. He then completed his fellowship in hematopathology at Brigham and Women’s Hospital / Harvard Medical School, Boston, MA.
Dr. Rohr studied functional genomics of peripheral T-cell lymphomas in the laboratory of Wing C. (John) Chan, MD. He was an ASCP 40 under Forty awardee. Dr. Rohr specializes in the diagnosis of lymphoid and myeloid neoplasms with particular research interests in T-cell lymphoma biology, digital pathology applications in clinical and research practice, and evidence-based pedagogy.
